尤瑞克林治疗急性脑梗死的临床疗效探讨
摘要
关键词
全文:
PDF参考
[1]黄铭娜,任丽,吴锡骅.尤瑞克林辅助治疗急性脑梗死的可行性及安全性[J].中国医药科学,2019,9(2):53-55,80. [2]林述洋,李聪,蒋智林.尤瑞克林治疗急性脑梗死早期取栓术后造影剂外渗疗效观察[J].临床军医杂志,2019,47(2):134-135,138. [3] Perilli V., Aceto P., Modesti C., Ciocchetti P., Sacco T., Vitale F., … Sollazzi L. (2012). Low values of left ventricular ejection time in the post anhepatic phase may be associated with the occurrence of primary graft dysfunction after orthotopic liver transplantation: Results of a singlecentre case control study. European Review for Medical and Pharmacological Sciences, 16, 1433 1440. [4] Ke J., & Jing M. (2016). Analysis of treatment effect of urinary kallidinogenase combined with edaravone on massive cerebral infarction. Biomedical Reports, 5, 155 158. 10.3892/br.2016.692 [5] Dong Han, Xin Chen, Dongmei Li, Shuang Liu, Yi Lyu, and Juan Feng.(2018). Human Urinary Kallidinogenase decreases recurrence risk and promotes good recovery. Brain and Behavior, 2018 Aug; 8(8): e01033.
DOI: http://dx.doi.org/10.18686/yxyj.v2i1.19365
Refbacks
- 当前没有refback。